| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.593 | 0.008 | 0.593 | GABA C receptor rho-3 antagonist | 0.424 0.051 CID_8656 | ||
| 0.547 | 0.017 | 0.547 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.545 0.017 CID_8656 | ||
| 0.521 | 0.008 | 0.521 | Peroxidase inhibitor | 0.259 0.045 CID_8656 | ||
| 0.512 | 0.024 | 0.512 | Calcium channel L-type activator | 0.443 0.055 CID_8656 | ||
| 0.487 | 0.035 | 0.487 | Aldehyde oxidase inhibitor | 0.175 0.119 CID_8656 | ||
| 0.443 | 0.037 | 0.443 | 5 Hydroxytryptamine release stimulant | 0.178 0.143 CID_8656 | ||
| 0.415 | 0.024 | 0.415 | Superoxide dismutase inhibitor | 0.215 0.102 CID_8656 | ||
| 0.444 | 0.054 | 0.547 | 5 Hydroxytryptamine release inhibitor | 0.547 0.02 CID_8656 | CID_8656 | |
| 0.406 | 0.022 | 0.406 | Calcium channel activator | 0.299 0.093 CID_8656 | ||
| 0.413 | 0.035 | 0.413 | Aryl hydrocarbon receptor agonist | 0.386 0.04 CID_8656 | ||
| 0.43 | 0.06 | 0.508 | Histamine release inhibitor | 0.508 0.026 CID_8656 | CID_8656 | |
| 0.413 | 0.047 | 0.413 | Cholesterol antagonist | 0.297 0.093 CID_8656 | ||
| 0.371 | 0.02 | 0.371 | Anesthetic general | 0.362 0.022 CID_8656 | ||
| 0.352 | 0.005 | 0.357 | Ferrochelatase inhibitor | 0.357 0.004 CID_8656 | CID_8656 | |
| 0.342 | 0.004 | 0.342 | MAP kinase kinase 3 inhibitor | 0.225 0.064 CID_8656 | ||
| 0.328 | 0.01 | 0.328 | MAP kinase 9 inhibitor | |||
| 0.344 | 0.027 | 0.344 | 5 Hydroxytryptamine uptake stimulant | 0.264 0.068 CID_8656 | ||
| 0.332 | 0.016 | 0.332 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.313 0.02 CID_8656 | ||
| 0.371 | 0.077 | 0.371 | MAP kinase kinase 6 inhibitor | |||
| 0.33 | 0.04 | 0.33 | Pyruvate kinase inhibitor | 0.235 0.066 CID_8656 | ||
| 0.312 | 0.026 | 0.312 | Gastrin inhibitor | 0.306 0.029 CID_8656 | ||
| 0.314 | 0.029 | 0.314 | RNA-directed DNA polymerase inhibitor | 0.22 0.073 CID_8656 | ||
| 0.312 | 0.028 | 0.312 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.059 CID_8656 | ||
| 0.293 | 0.013 | 0.293 | Anesthetic local | 0.251 0.02 CID_8656 | ||
| 0.295 | 0.019 | 0.295 | Lipid peroxidase inhibitor | 0.189 0.046 CID_8656 | ||
| 0.353 | 0.082 | 0.353 | Prostaglandin dehydrogenase inhibitor | 0.261 0.121 CID_8656 | ||
| 0.385 | 0.12 | 0.459 | Caspase 9 stimulant | 0.459 0.078 CID_8656 | CID_8656 | |
| 0.272 | 0.008 | 0.272 | Mannose-6-phosphate isomerase inhibitor | 0.179 0.043 CID_8656 | ||
| 0.32 | 0.059 | 0.374 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.374 0.044 CID_8656 | CID_8656 | |
| 0.279 | 0.018 | 0.279 | Heat shock protein 90 alpha antagonist | 0.229 0.035 CID_8656 | ||
| 0.268 | 0.009 | 0.268 | MAP kinase 8 inhibitor | |||
| 0.277 | 0.018 | 0.277 | Nitric-oxide synthase stimulant | 0.231 0.048 CID_8656 | ||
| 0.27 | 0.014 | 0.286 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.286 0.013 CID_8656 | CID_8656 | |
| 0.264 | 0.012 | 0.264 | GABA C receptor agonist | 0.115 0.053 CID_8656 | ||
| 0.315 | 0.064 | 0.388 | Interleukin 2 agonist | 0.388 0.031 CID_8656 | CID_8656 | |
| 0.299 | 0.048 | 0.396 | Interleukin agonist | 0.396 0.019 CID_8656 | CID_8656 | |
| 0.255 | 0.01 | 0.255 | Platelet activating factor alpha antagonist | 0.241 0.011 CID_8656 | ||
| 0.3 | 0.059 | 0.317 | Insulysin inhibitor | 0.317 0.049 CID_8656 | CID_8656 | |
| 0.259 | 0.021 | 0.515 | Alpha-N-acetylglucosaminidase inhibitor | 0.515 0.005 CID_8656 | CID_8656 | |
| 0.276 | 0.043 | 0.276 | Sigma receptor agonist | 0.193 0.064 CID_8656 | ||
| 0.262 | 0.032 | 0.262 | Neurotrophic factor enhancer | 0.199 0.078 CID_8656 | ||
| 0.243 | 0.013 | 0.243 | GABA C receptor rho-2 antagonist | 0.159 0.063 CID_8656 | ||
| 0.256 | 0.032 | 0.256 | Lipocortins synthesis antagonist | |||
| 0.239 | 0.021 | 0.284 | 5 Hydroxytryptamine 3E antagonist | 0.284 0.007 CID_8656 | CID_8656 | |
| 0.239 | 0.024 | 0.239 | Heat shock protein 90 antagonist | 0.167 0.058 CID_8656 | ||
| 0.269 | 0.054 | 0.278 | 5 Hydroxytryptamine 1E antagonist | 0.278 0.047 CID_8656 | CID_8656 | |
| 0.217 | 0.005 | 0.217 | Biliverdin reductase inhibitor | 0.141 0.01 CID_8656 | ||
| 0.226 | 0.015 | 0.226 | Carbonic anhydrase XV inhibitor | 0.155 0.029 CID_8656 | ||
| 0.218 | 0.01 | 0.218 | GABA C receptor antagonist | 0.119 0.054 CID_8656 | ||
| 0.346 | 0.14 | 0.528 | DNA directed DNA polymerase inhibitor | 0.528 0.074 CID_8656 | CID_8656 | |
| 0.213 | 0.009 | 0.213 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 CID_8656 | ||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | 0.253 0.162 CID_8656 | ||
| 0.211 | 0.01 | 0.211 | NADH dehydrogenase inhibitor | 0.118 0.03 CID_8656 | ||
| 0.258 | 0.061 | 0.258 | DNA synthesis inhibitor | 0.181 0.152 CID_8656 | ||
| 0.239 | 0.044 | 0.239 | LIM domain kinase 1 inhibitor | 0.173 0.078 CID_8656 | ||
| 0.242 | 0.049 | 0.242 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.198 | 0.005 | 0.198 | NMDA 2C receptor antagonist | 0.121 0.01 CID_8656 | ||
| 0.2 | 0.008 | 0.2 | GABA C receptor rho-1 antagonist | 0.118 0.041 CID_8656 | ||
| 0.225 | 0.033 | 0.225 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_8656 | ||
| 0.247 | 0.058 | 0.247 | Anticonvulsant | |||
| 0.301 | 0.113 | 0.454 | Calpain 2 inhibitor | 0.454 0.037 CID_8656 | CID_8656 | |
| 0.245 | 0.061 | 0.279 | Neuropeptide Y2 antagonist | 0.279 0.031 CID_8656 | CID_8656 | |
| 0.194 | 0.01 | 0.194 | Nitric-oxide synthase inhibitor | 0.091 0.077 CID_8656 | ||
| 0.224 | 0.04 | 0.224 | Protein kinase C nu inhibitor | |||
| 0.194 | 0.012 | 0.237 | Papain-like protease (SARS coronavirus) inhibitor | 0.237 0.005 CID_8656 | CID_8656 | |
| 0.195 | 0.013 | 0.195 | Porphobilinogen synthase inhibitor | 0.131 0.025 CID_8656 | ||
| 0.219 | 0.038 | 0.219 | Amylase inhibitor | 0.099 0.097 CID_8656 | ||
| 0.33 | 0.149 | 0.539 | DNA polymerase beta inhibitor | 0.539 0.075 CID_8656 | CID_8656 | |
| 0.186 | 0.008 | 0.186 | Toll-Like receptor 3 antagonist | 0.111 0.037 CID_8656 | ||
| 0.19 | 0.018 | 0.19 | 5 Hydroxytryptamine 3A agonist | |||
| 0.203 | 0.032 | 0.293 | M17 leucyl aminopeptidase inhibitor | 0.293 0.013 CID_8656 | CID_8656 | |
| 0.194 | 0.024 | 0.194 | Cathepsin H inhibitor | 0.171 0.033 CID_8656 | ||
| 0.214 | 0.044 | 0.276 | 3C-like protease (Human coronavirus) inhibitor | 0.276 0.018 CID_8656 | CID_8656 | |
| 0.17 | 0.005 | 0.17 | GABA aminotransferase inhibitor | 0.101 0.027 CID_8656 | ||
| 0.229 | 0.064 | 0.229 | MAP kinase kinase 2 inhibitor | 0.169 0.104 CID_8656 | ||
| 0.321 | 0.158 | 0.321 | MAP kinase 1 inhibitor | 0.314 0.165 CID_8656 | ||
| 0.19 | 0.028 | 0.19 | CF transmembrane conductance regulator agonist | 0.181 0.035 CID_8656 | ||
| 0.278 | 0.116 | 0.361 | Thioredoxin glutathione reductase inhibitor | 0.361 0.072 CID_8656 | CID_8656 | |
| 0.173 | 0.011 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.151 0.041 CID_8656 | ||
| 0.185 | 0.028 | 0.185 | Cystathionine beta-synthase inhibitor | 0.099 0.078 CID_8656 | ||
| 0.307 | 0.151 | 0.47 | Transcription factor inhibitor | 0.47 0.084 CID_8656 | CID_8656 | |
| 0.193 | 0.039 | 0.193 | Arachidonic acid antagonist | 0.141 0.099 CID_8656 | ||
| 0.158 | 0.005 | 0.158 | Potassium channel (ATP-sensitive) blocker | 0.124 0.008 CID_8656 | ||
| 0.173 | 0.02 | 0.173 | Adenylate kinase inhibitor | 0.104 0.062 CID_8656 | ||
| 0.171 | 0.018 | 0.171 | Gastric antisecretory | 0.134 0.035 CID_8656 | ||
| 0.171 | 0.021 | 0.171 | Photosensitizer | 0.112 0.068 CID_8656 | ||
| 0.196 | 0.046 | 0.196 | Phospholipase C inhibitor | 0.155 0.097 CID_8656 | ||
| 0.189 | 0.042 | 0.25 | Hexokinase inhibitor | 0.25 0.017 CID_8656 | CID_8656 | |
| 0.175 | 0.029 | 0.192 | Sphingosine 1-phosphate receptor 5 antagonist | 0.192 0.015 CID_8656 | CID_8656 | |
| 0.165 | 0.02 | 0.165 | DNA directed RNA polymerase inhibitor | |||
| 0.172 | 0.027 | 0.193 | Interleukin 1b antagonist | 0.193 0.021 CID_8656 | CID_8656 | |
| 0.191 | 0.047 | 0.191 | Interleukin 6 antagonist | |||
| 0.189 | 0.047 | 0.196 | ATPase inhibitor | 0.196 0.04 CID_8656 | CID_8656 | |
| 0.165 | 0.024 | 0.193 | UDP-glucose 4-epimerase inhibitor | 0.193 0.019 CID_8656 | CID_8656 | |
| 0.158 | 0.018 | 0.158 | Triose-phosphate isomerase inhibitor | 0.144 0.022 CID_8656 | ||
| 0.186 | 0.047 | 0.186 | Protein kinase stimulant | 0.147 0.071 CID_8656 | ||
| 0.172 | 0.033 | 0.172 | Adenylate cyclase stimulant | 0.125 0.112 CID_8656 | ||
| 0.194 | 0.057 | 0.194 | Tumour necrosis factor antagonist | 0.145 0.108 CID_8656 | ||
| 0.184 | 0.048 | 0.184 | Lck kinase inhibitor | |||
| 0.158 | 0.024 | 0.216 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.216 0.013 CID_8656 | CID_8656 | |
| 0.201 | 0.068 | 0.201 | Histone acetyltransferase inhibitor | |||
| 0.149 | 0.017 | 0.149 | NMDA 2 receptor antagonist | 0.077 0.045 CID_8656 | ||
| 0.136 | 0.005 | 0.136 | Estrogen-related receptor beta agonist | 0.096 0.029 CID_8656 | ||
| 0.18 | 0.05 | 0.18 | Neurotensin receptor agonist | 0.163 0.074 CID_8656 | ||
| 0.147 | 0.017 | 0.147 | CYP2A6 inhibitor | |||
| 0.152 | 0.023 | 0.152 | Creatine kinase inhibitor | 0.104 0.055 CID_8656 | ||
| 0.215 | 0.087 | 0.215 | Angiogenesis stimulant | |||
| 0.133 | 0.005 | 0.133 | H+/K+-transporting ATPase inhibitor | |||
| 0.17 | 0.043 | 0.17 | M18 aspartyl aminopeptidase inhibitor | 0.131 0.063 CID_8656 | ||
| 0.15 | 0.023 | 0.15 | Transcription factor STAT6 inhibitor | 0.14 0.032 CID_8656 | ||
| 0.209 | 0.084 | 0.209 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.201 | 0.076 | 0.201 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.137 | 0.014 | 0.137 | Myeloperoxidase inhibitor | 0.079 0.069 CID_8656 | ||
| 0.132 | 0.009 | 0.132 | D-Ala-D-Ala ligase inhibitor | 0.1 0.029 CID_8656 | ||
| 0.174 | 0.054 | 0.174 | Interferon gamma antagonist | 0.158 0.068 CID_8656 | ||
| 0.159 | 0.039 | 0.159 | Adenylate cyclase inhibitor | |||
| 0.142 | 0.023 | 0.154 | Electrolyte absorption antagonist | 0.154 0.018 CID_8656 | CID_8656 | |
| 0.131 | 0.012 | 0.131 | T cell inhibitor | 0.102 0.023 CID_8656 | ||
| 0.155 | 0.036 | 0.159 | Heat shock protein 70 antagonist | 0.159 0.029 CID_8656 | CID_8656 | |
| 0.186 | 0.07 | 0.186 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.153 | 0.037 | 0.182 | Sphingosine 1-phosphate receptor 2 antagonist | 0.182 0.014 CID_8656 | CID_8656 | |
| 0.143 | 0.027 | 0.163 | Urease inhibitor | 0.163 0.018 CID_8656 | CID_8656 | |
| 0.123 | 0.008 | 0.164 | NMDA receptor glycine site agonist | 0.164 0.004 CID_8656 | CID_8656 | |
| 0.134 | 0.019 | 0.134 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.118 | 0.004 | 0.118 | Sodium/calcium exchanger inhibitor | |||
| 0.133 | 0.02 | 0.133 | Interleukin 12 antagonist | 0.101 0.052 CID_8656 | ||
| 0.165 | 0.052 | 0.165 | Cell wall synthesis inhibitor | 0.16 0.056 CID_8656 | ||
| 0.156 | 0.044 | 0.156 | Aldehyde dehydrogenase inhibitor | |||
| 0.129 | 0.017 | 0.129 | Glutamate release inhibitor | |||
| 0.125 | 0.013 | 0.125 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.064 CID_8656 | ||
| 0.13 | 0.019 | 0.13 | HIV-1 reverse transcriptase inhibitor | |||
| 0.123 | 0.012 | 0.171 | NMDA receptor agonist | 0.171 0.006 CID_8656 | CID_8656 | |
| 0.19 | 0.08 | 0.19 | I kappa B kinase epsilon inhibitor | |||
| 0.19 | 0.08 | 0.19 | Non-steroidal antiinflammatory agent | 0.164 0.1 CID_8656 | ||
| 0.134 | 0.024 | 0.134 | MAP kinase kinase 1 inhibitor | 0.092 0.068 CID_8656 | ||
| 0.12 | 0.011 | 0.12 | Purinergic P2X1 antagonist | 0.058 0.047 CID_8656 | ||
| 0.131 | 0.023 | 0.131 | Histamine N-methyltransferase inhibitor | |||
| 0.115 | 0.007 | 0.115 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 CID_8656 | ||
| 0.14 | 0.033 | 0.142 | Carbonic anhydrase III inhibitor | 0.142 0.032 CID_8656 | CID_8656 | |
| 0.198 | 0.091 | 0.198 | ErbB-1 antagonist | 0.162 0.149 CID_8656 | ||
| 0.245 | 0.14 | 0.245 | Vasodilator, coronary | |||
| 0.126 | 0.023 | 0.126 | Inducible nitric-oxide synthase inhibitor | |||
| 0.143 | 0.04 | 0.188 | Sphingosine 1-phosphate receptor 4 antagonist | 0.188 0.012 CID_8656 | CID_8656 | |
| 0.162 | 0.06 | 0.162 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.116 | 0.015 | 0.116 | Alcohol oxidase inhibitor | 0.094 0.019 CID_8656 | ||
| 0.159 | 0.058 | 0.159 | Hemostatic | 0.13 0.096 CID_8656 | ||
| 0.131 | 0.031 | 0.131 | NMDA receptor antagonist | 0.082 0.063 CID_8656 | ||
| 0.187 | 0.087 | 0.192 | Insulin sensitizer | 0.192 0.081 CID_8656 | CID_8656 | |
| 0.14 | 0.041 | 0.14 | Interleukin 8 antagonist | 0.107 0.083 CID_8656 | ||
| 0.126 | 0.027 | 0.126 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.083 0.049 CID_8656 | ||
| 0.14 | 0.042 | 0.14 | Aminopeptidase B inhibitor | 0.105 0.062 CID_8656 | ||
| 0.117 | 0.019 | 0.117 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.049 CID_8656 | ||
| 0.272 | 0.175 | 0.445 | Alpha-glucosidase inhibitor | 0.445 0.098 CID_8656 | CID_8656 | |
| 0.124 | 0.027 | 0.156 | Glutamate (mGluR7) agonist | 0.156 0.01 CID_8656 | CID_8656 | |
| 0.147 | 0.051 | 0.197 | Cyclooxygenase 3 inhibitor | 0.197 0.02 CID_8656 | CID_8656 | |
| 0.131 | 0.034 | 0.131 | DOPA decarboxylase inhibitor | |||
| 0.173 | 0.078 | 0.173 | MAP kinase kinase 5 inhibitor | |||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR6) antagonist | 0.069 0.041 CID_8656 | ||
| 0.149 | 0.057 | 0.149 | Cyclooxygenase 1 inhibitor | |||
| 0.149 | 0.058 | 0.149 | Interleukin 1 antagonist | 0.142 0.063 CID_8656 | ||
| 0.166 | 0.075 | 0.255 | Death-associated protein kinase 2 inhibitor | 0.255 0.012 CID_8656 | CID_8656 | |
| 0.128 | 0.037 | 0.128 | Acetylcholine release stimulant | 0.103 0.081 CID_8656 | ||
| 0.136 | 0.046 | 0.136 | Microtubule formation inhibitor | 0.102 0.087 CID_8656 | ||
| 0.113 | 0.025 | 0.113 | Glutamate dehydrogenase inhibitor | 0.082 0.043 CID_8656 | ||
| 0.227 | 0.139 | 0.424 | Thyroid hormone antagonist | 0.424 0.049 CID_8656 | CID_8656 | |
| 0.151 | 0.063 | 0.151 | Ribosomal protein S6 kinase inhibitor | |||
| 0.118 | 0.03 | 0.118 | Carbonic anhydrase VI inhibitor | 0.086 0.05 CID_8656 | ||
| 0.105 | 0.018 | 0.105 | Glycine receptor agonist | 0.067 0.061 CID_8656 | ||
| 0.094 | 0.008 | 0.094 | Potassium channel (Inward rectifier) blocker | 0.07 0.017 CID_8656 | ||
| 0.146 | 0.059 | 0.146 | Nav1.2 sodium channel blocker | 0.121 0.082 CID_8656 | ||
| 0.217 | 0.133 | 0.232 | 12-Lipoxygenase inhibitor | 0.232 0.121 CID_8656 | CID_8656 | |
| 0.111 | 0.028 | 0.111 | Histidine decarboxylase inhibitor | |||
| 0.096 | 0.013 | 0.096 | Glutamate (mGluR7) antagonist | 0.067 0.048 CID_8656 | ||
| 0.092 | 0.009 | 0.092 | Transcription factor RelA inhibitor | 0.068 0.034 CID_8656 | ||
| 0.144 | 0.062 | 0.144 | Nav1.6 sodium channel blocker | |||
| 0.121 | 0.039 | 0.121 | Anabolic | 0.11 0.049 CID_8656 | ||
| 0.122 | 0.04 | 0.122 | Potassium channel (Ca-activated) activator | |||
| 0.211 | 0.13 | 0.211 | Lipoxygenase inhibitor | 0.175 0.17 CID_8656 | ||
| 0.155 | 0.074 | 0.155 | Diuretic | 0.12 0.105 CID_8656 | ||
| 0.101 | 0.02 | 0.123 | CC chemokine 5 receptor agonist | 0.123 0.008 CID_8656 | CID_8656 | |
| 0.1 | 0.019 | 0.1 | Argininosuccinate synthase inhibitor | |||
| 0.227 | 0.147 | 0.253 | Vasodilator, peripheral | 0.253 0.125 CID_8656 | CID_8656 | |
| 0.138 | 0.058 | 0.138 | MAP kinase kinase inhibitor | |||
| 0.087 | 0.008 | 0.123 | Dihydroorotate oxidase inhibitor | 0.123 0.004 CID_8656 | CID_8656 | |
| 0.115 | 0.036 | 0.138 | Potassium channel (Voltage-sensitive) activator | 0.138 0.018 CID_8656 | CID_8656 | |
| 0.094 | 0.015 | 0.094 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.082 | 0.004 | 0.082 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.025 CID_8656 | ||
| 0.084 | 0.006 | 0.084 | Adenylate cyclase 1 inhibitor | 0.056 0.021 CID_8656 | ||
| 0.217 | 0.14 | 0.422 | Thyroid hormone beta antagonist | 0.422 0.047 CID_8656 | CID_8656 | |
| 0.106 | 0.029 | 0.106 | Phosphofructokinase-1 inhibitor | |||
| 0.127 | 0.051 | 0.151 | TRPA1 agonist | 0.151 0.03 CID_8656 | CID_8656 | |
| 0.104 | 0.028 | 0.104 | mTOR complex 2 inhibitor | |||
| 0.084 | 0.009 | 0.084 | Kainate receptor antagonist | |||
| 0.09 | 0.016 | 0.09 | NMDA 2A receptor antagonist | |||
| 0.193 | 0.12 | 0.262 | Calpain inhibitor | 0.262 0.054 CID_8656 | CID_8656 | |
| 0.145 | 0.073 | 0.145 | Neuropeptide Y1 antagonist | 0.143 0.076 CID_8656 | ||
| 0.09 | 0.019 | 0.09 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.037 CID_8656 | ||
| 0.099 | 0.029 | 0.099 | Interferon agonist | |||
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | 0.076 0.059 CID_8656 | ||
| 0.081 | 0.011 | 0.081 | NMDA receptor subunit 3A antagonist | |||
| 0.074 | 0.005 | 0.074 | Dihydrofolate reductase inhibitor | |||
| 0.092 | 0.023 | 0.092 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.169 | 0.101 | 0.173 | Focal adhesion kinase 2 inhibitor | 0.173 0.096 CID_8656 | CID_8656 | |
| 0.076 | 0.009 | 0.076 | Thymidylate synthase inhibitor | 0.041 0.039 CID_8656 | ||
| 0.131 | 0.064 | 0.131 | Vanilloid 1 agonist | 0.128 0.07 CID_8656 | ||
| 0.12 | 0.054 | 0.133 | Mucolytic | 0.133 0.043 CID_8656 | CID_8656 | |
| 0.126 | 0.06 | 0.126 | Platelet activating factor antagonist | 0.097 0.081 CID_8656 | ||
| 0.077 | 0.011 | 0.077 | Ryanodine receptor antagonist | |||
| 0.075 | 0.01 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | 0.044 0.033 CID_8656 | ||
| 0.133 | 0.068 | 0.157 | NADPH oxidase inhibitor | 0.157 0.05 CID_8656 | CID_8656 | |
| 0.085 | 0.02 | 0.085 | Carbonic anhydrase VB inhibitor | 0.069 0.028 CID_8656 | ||
| 0.073 | 0.009 | 0.073 | Estrogen-related receptor alpha antagonist | |||
| 0.071 | 0.007 | 0.071 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 CID_8656 | ||
| 0.106 | 0.043 | 0.106 | ABCA1 expression enhancer | |||
| 0.096 | 0.033 | 0.096 | Keratolytic | 0.08 0.049 CID_8656 | ||
| 0.187 | 0.126 | 0.187 | DNA damaging | |||
| 0.093 | 0.032 | 0.093 | Aminopeptidase I inhibitor | 0.078 0.044 CID_8656 | ||
| 0.138 | 0.078 | 0.153 | Pregnane X receptor agonist | 0.153 0.048 CID_8656 | CID_8656 | |
| 0.124 | 0.064 | 0.124 | DNA repair enzyme inhibitor | |||
| 0.149 | 0.09 | 0.149 | Mcl-1 antagonist | |||
| 0.082 | 0.023 | 0.082 | Androgen agonist | 0.064 0.036 CID_8656 | ||
| 0.187 | 0.128 | 0.187 | Immunostimulant | 0.177 0.135 CID_8656 | ||
| 0.207 | 0.148 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.087 | 0.029 | 0.087 | GABA B receptor agonist | 0.08 0.041 CID_8656 | ||
| 0.081 | 0.023 | 0.081 | Interferon inducer | |||
| 0.067 | 0.009 | 0.067 | Dihydropteroate synthase inhibitor | 0.049 0.017 CID_8656 | ||
| 0.163 | 0.106 | 0.163 | Psychostimulant | |||
| 0.074 | 0.017 | 0.074 | Aconitate hydratase inhibitor | |||
| 0.092 | 0.035 | 0.092 | Glutamate decarboxylase inhibitor | |||
| 0.088 | 0.032 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.075 | 0.02 | 0.075 | Calcium channel P-type blocker | |||
| 0.087 | 0.032 | 0.095 | Carbonic anhydrase VA inhibitor | 0.095 0.027 CID_8656 | CID_8656 | |
| 0.076 | 0.021 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.07 0.029 CID_8656 | ||
| 0.111 | 0.056 | 0.121 | Beta glucuronidase inhibitor | 0.121 0.045 CID_8656 | CID_8656 | |
| 0.121 | 0.066 | 0.121 | Beta amyloid protein antagonist | |||
| 0.095 | 0.04 | 0.095 | Carbonic anhydrase XIII inhibitor | 0.076 0.053 CID_8656 | ||
| 0.078 | 0.023 | 0.078 | MDM2 inhibitor | |||
| 0.097 | 0.043 | 0.1 | Bcr-Abl kinase inhibitor | 0.1 0.041 CID_8656 | CID_8656 | |
| 0.24 | 0.187 | 0.24 | Antibacterial | |||
| 0.059 | 0.007 | 0.059 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.078 | 0.028 | 0.078 | Exportin-1 inhibitor | |||
| 0.122 | 0.072 | 0.122 | Glutamate receptor antagonist | |||
| 0.091 | 0.041 | 0.091 | MAP kinase 10 inhibitor | |||
| 0.084 | 0.034 | 0.096 | Carbonic anhydrase V inhibitor | 0.096 0.028 CID_8656 | CID_8656 | |
| 0.058 | 0.008 | 0.058 | Glutamate (mGluR8) agonist | 0.041 0.021 CID_8656 | ||
| 0.076 | 0.027 | 0.076 | Alpha 2 adrenoreceptor agonist | |||
| 0.078 | 0.029 | 0.078 | Aromatase inhibitor | |||
| 0.07 | 0.021 | 0.07 | AMPA receptor antagonist | |||
| 0.065 | 0.016 | 0.065 | Immunoglobulin Fc receptor antagonist | 0.057 0.032 CID_8656 | ||
| 0.059 | 0.011 | 0.059 | Inosine monophosphate dehydrogenase inhibitor | 0.053 0.013 CID_8656 | ||
| 0.051 | 0.003 | 0.051 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.036 0.003 CID_8656 | ||
| 0.097 | 0.049 | 0.123 | Androgen antagonist | 0.123 0.032 CID_8656 | CID_8656 | |
| 0.073 | 0.025 | 0.082 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.082 0.018 CID_8656 | CID_8656 | |
| 0.057 | 0.01 | 0.057 | Potassium channel Kv1.1 blocker | 0.055 0.01 CID_8656 | ||
| 0.06 | 0.013 | 0.06 | Geranyltranstransferase inhibitor | |||
| 0.077 | 0.029 | 0.077 | 5 Hydroxytryptamine 3 agonist | |||
| 0.067 | 0.02 | 0.067 | Lysine-specific demethylase 1A inhibitor | |||
| 0.134 | 0.088 | 0.226 | Cytidine deaminase inhibitor | 0.226 0.037 CID_8656 | CID_8656 | |
| 0.108 | 0.063 | 0.108 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.065 | 0.019 | 0.065 | Topoisomerase II beta inhibitor | 0.056 0.026 CID_8656 | ||
| 0.122 | 0.078 | 0.122 | Tubulin antagonist | |||
| 0.192 | 0.15 | 0.279 | Transcription factor STAT inhibitor | 0.279 0.068 CID_8656 | CID_8656 | |
| 0.058 | 0.016 | 0.058 | Histamine H2 receptor agonist | 0.042 0.031 CID_8656 | ||
| 0.167 | 0.126 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.105 | 0.063 | 0.105 | Expectorant | 0.103 0.065 CID_8656 | ||
| 0.055 | 0.014 | 0.055 | Dopamine D5 agonist | |||
| 0.079 | 0.039 | 0.079 | Cyclin B3 inhibitor | |||
| 0.098 | 0.057 | 0.098 | Phosphodiesterase 6D inhibitor | 0.087 0.085 CID_8656 | ||
| 0.096 | 0.056 | 0.096 | Alcohol dehydrogenase inhibitor | |||
| 0.071 | 0.031 | 0.071 | Carbonic anhydrase stimulant | 0.067 0.034 CID_8656 | ||
| 0.097 | 0.057 | 0.097 | Bile acid receptor antagonist | 0.087 0.081 CID_8656 | ||
| 0.135 | 0.095 | 0.135 | Src kinase inhibitor | |||
| 0.059 | 0.021 | 0.059 | Adenosine deaminase inhibitor | |||
| 0.093 | 0.056 | 0.152 | Potassium channel activator | 0.152 0.019 CID_8656 | CID_8656 | |
| 0.052 | 0.015 | 0.052 | Nerve growth factor antagonist | 0.047 0.022 CID_8656 | ||
| 0.055 | 0.018 | 0.055 | Cytokine production stimulant | |||
| 0.053 | 0.018 | 0.053 | Guanylate cyclase inhibitor | |||
| 0.063 | 0.028 | 0.099 | Acetyl-CoA transferase inhibitor | 0.099 0.014 CID_8656 | CID_8656 | |
| 0.062 | 0.027 | 0.062 | Pregnane X receptor antagonist | 0.056 0.042 CID_8656 | ||
| 0.08 | 0.045 | 0.08 | MAP kinase 7 inhibitor | |||
| 0.153 | 0.118 | 0.153 | Death-associated protein kinase 3 inhibitor | |||
| 0.042 | 0.008 | 0.048 | NMDA receptor glycine site antagonist | 0.048 0.006 CID_8656 | CID_8656 | |
| 0.086 | 0.053 | 0.086 | MAP-kinase-activated kinase inhibitor | |||
| 0.089 | 0.057 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.085 0.064 CID_8656 | ||
| 0.101 | 0.069 | 0.157 | Falcipain 3 inhibitor | 0.157 0.033 CID_8656 | CID_8656 | |
| 0.075 | 0.043 | 0.075 | Phospholipase D inhibitor | |||
| 0.047 | 0.016 | 0.051 | Diamine oxidase inhibitor | 0.051 0.014 CID_8656 | CID_8656 | |
| 0.06 | 0.029 | 0.06 | Epithelial sodium channel blocker | |||
| 0.094 | 0.062 | 0.094 | Prolactin inhibitor | |||
| 0.044 | 0.013 | 0.044 | Potassium channel small-conductance Ca-activated activator | |||
| 0.046 | 0.016 | 0.046 | Retinoid X alpha receptor agonist | |||
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | 0.044 0.03 CID_8656 | ||
| 0.088 | 0.057 | 0.088 | Calcium antagonist | |||
| 0.091 | 0.061 | 0.091 | Thioredoxin inhibitor | |||
| 0.063 | 0.033 | 0.066 | Botulinum neurotoxin type A inhibitor | 0.066 0.03 CID_8656 | CID_8656 | |
| 0.089 | 0.06 | 0.089 | Pim-3 kinase inhibitor | |||
| 0.077 | 0.048 | 0.077 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.199 | 0.17 | 0.199 | Transcription factor NF kappa B inhibitor | 0.193 0.176 CID_8656 | ||
| 0.049 | 0.02 | 0.049 | Histamine H1 receptor agonist | |||
| 0.075 | 0.047 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 CID_8656 | ||
| 0.035 | 0.006 | 0.035 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.024 0.011 CID_8656 | ||
| 0.051 | 0.023 | 0.095 | Dihydroorotase inhibitor | 0.095 0.006 CID_8656 | CID_8656 | |
| 0.096 | 0.068 | 0.096 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.05 | 0.022 | 0.05 | AICAR transformylase inhibitor | 0.043 0.033 CID_8656 | ||
| 0.036 | 0.008 | 0.036 | Estrogen-related receptor gamma antagonist | 0.027 0.023 CID_8656 | ||
| 0.032 | 0.005 | 0.032 | Alpha 2a adrenoreceptor agonist | |||
| 0.073 | 0.046 | 0.073 | Secretase beta inhibitor | |||
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | |||
| 0.076 | 0.049 | 0.08 | Adenosine A3 receptor antagonist | 0.08 0.043 CID_8656 | CID_8656 | |
| 0.117 | 0.09 | 0.117 | Alkaline phosphatase inhibitor | 0.116 0.091 CID_8656 | ||
| 0.122 | 0.095 | 0.122 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.081 | 0.055 | 0.114 | Glycine receptor antagonist | 0.114 0.022 CID_8656 | CID_8656 | |
| 0.063 | 0.037 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.079 | 0.053 | 0.079 | Glutamate receptor agonist | |||
| 0.05 | 0.024 | 0.05 | Glutamate (mGluR group III) agonist | |||
| 0.059 | 0.033 | 0.059 | Sphingosine kinase 2 inhibitor | |||
| 0.079 | 0.053 | 0.079 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.037 | 0.011 | 0.037 | CDK4/cyclin D3 inhibitor | |||
| 0.206 | 0.181 | 0.483 | Beta lactamase inhibitor | 0.483 0.078 CID_8656 | CID_8656 | |
| 0.038 | 0.012 | 0.038 | Glutamate (mGluR3) agonist | 0.031 0.027 CID_8656 | ||
| 0.067 | 0.041 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | 0.076 0.031 CID_8656 | CID_8656 | |
| 0.101 | 0.075 | 0.101 | Monophenol monooxygenase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.07 | 0.045 | 0.07 | Alpha adrenoreceptor agonist | |||
| 0.096 | 0.071 | 0.096 | mTOR complex 1 inhibitor | |||
| 0.052 | 0.027 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 CID_8656 | ||
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR3) antagonist | |||
| 0.032 | 0.008 | 0.032 | Glutamate (mGluR1a) agonist | 0.021 0.017 CID_8656 | ||
| 0.077 | 0.052 | 0.105 | Sphingosine 1-phosphate receptor antagonist | 0.105 0.019 CID_8656 | CID_8656 | |
| 0.125 | 0.101 | 0.125 | Acetylcholine M1 receptor antagonist | |||
| 0.082 | 0.058 | 0.101 | Glutathione S-transferase inhibitor | 0.101 0.036 CID_8656 | CID_8656 | |
| 0.12 | 0.096 | 0.12 | Activin receptor-like kinase 2 inhibitor | |||
| 0.044 | 0.02 | 0.044 | AMPA 4 receptor antagonist | |||
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | |||
| 0.052 | 0.029 | 0.052 | CC chemokine receptor 2B antagonist | |||
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.115 | 0.092 | 0.115 | Toll-Like receptor 9 antagonist | |||
| 0.099 | 0.077 | 0.128 | Protein kinase (CK2) alpha inhibitor | 0.128 0.056 CID_8656 | CID_8656 | |
| 0.114 | 0.091 | 0.153 | Antibacterial (Helicobacter pylori) | 0.153 0.043 CID_8656 | CID_8656 | |
| 0.042 | 0.02 | 0.042 | Retinoid X receptor antagonist | |||
| 0.131 | 0.108 | 0.131 | Polo-like kinase-3 inhibitor | |||
| 0.13 | 0.108 | 0.13 | MAP kinase 3 inhibitor | 0.129 0.108 CID_8656 | ||
| 0.044 | 0.022 | 0.044 | GABA uptake inhibitor | |||
| 0.138 | 0.116 | 0.138 | Amyloid beta precursor protein antagonist | |||
| 0.092 | 0.07 | 0.092 | MAO A inhibitor | |||
| 0.084 | 0.062 | 0.084 | Ornithine decarboxylase inhibitor | |||
| 0.044 | 0.022 | 0.044 | Kainate receptor agonist | |||
| 0.029 | 0.008 | 0.029 | Imidazoline I1 receptor antagonist | 0.029 0.007 CID_8656 | ||
| 0.052 | 0.031 | 0.052 | Carbonic anhydrase XIV inhibitor | |||
| 0.076 | 0.055 | 0.076 | Na+ K+ transporting ATPase inhibitor | |||
| 0.025 | 0.005 | 0.025 | Estrogen-related receptor gamma agonist | 0.02 0.011 CID_8656 | ||
| 0.042 | 0.021 | 0.062 | Potassium channel KCNQ activator | 0.062 0.009 CID_8656 | CID_8656 | |
| 0.042 | 0.021 | 0.062 | Delayed rectifier potassium channel activator | 0.062 0.009 CID_8656 | CID_8656 | |
| 0.093 | 0.072 | 0.093 | Insulin receptor antagonist | |||
| 0.072 | 0.051 | 0.072 | Cathepsin G inhibitor | |||
| 0.104 | 0.084 | 0.104 | Alkylator | |||
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.131 | 0.112 | 0.131 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.114 | 0.094 | 0.114 | Toll-Like receptor antagonist | |||
| 0.042 | 0.022 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.025 | 0.006 | 0.025 | Alpha 2c adrenoreceptor agonist | 0.024 0.007 CID_8656 | ||
| 0.065 | 0.046 | 0.065 | Histone deacetylase inhibitor | |||
| 0.055 | 0.035 | 0.055 | Ornithine carbamoyltransferase inhibitor | |||
| 0.095 | 0.076 | 0.127 | Mediator release inhibitor | 0.127 0.042 CID_8656 | CID_8656 | |
| 0.038 | 0.019 | 0.038 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.061 | 0.042 | 0.071 | Cyclin D1 inhibitor | 0.071 0.027 CID_8656 | CID_8656 | |
| 0.187 | 0.168 | 0.187 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.037 | 0.018 | 0.039 | Adenosine uptake inhibitor | 0.039 0.014 CID_8656 | CID_8656 | |
| 0.053 | 0.034 | 0.112 | Dihydroorotate dehydrogenase inhibitor | 0.112 0.009 CID_8656 | CID_8656 | |
| 0.05 | 0.031 | 0.05 | Dopamine beta hydroxylase inhibitor | |||
| 0.055 | 0.037 | 0.055 | CC chemokine 2 receptor antagonist | |||
| 0.059 | 0.041 | 0.059 | Beta tubulin antagonist | |||
| 0.079 | 0.061 | 0.079 | I kappa B kinase inhibitor | |||
| 0.032 | 0.014 | 0.032 | Purinergic P2Y15 antagonist | 0.028 0.022 CID_8656 | ||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.064 | 0.047 | 0.064 | Aryl hydrocarbon receptor antagonist | |||
| 0.039 | 0.023 | 0.039 | Retinoid X receptor agonist | |||
| 0.055 | 0.039 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | 0.071 0.018 CID_8656 | CID_8656 | |
| 0.066 | 0.049 | 0.066 | Acetylcholine M5 receptor agonist | |||
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.053 | 0.037 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.13 | 0.114 | 0.13 | Melanin inhibitor | |||
| 0.073 | 0.058 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.053 | 0.038 | 0.053 | Alpha-mannosidase inhibitor | |||
| 0.072 | 0.057 | 0.075 | Vanilloid 4 agonist | 0.075 0.051 CID_8656 | CID_8656 | |
| 0.053 | 0.038 | 0.053 | Alpha tubulin antagonist | |||
| 0.036 | 0.022 | 0.036 | Fumarate hydratase inhibitor | |||
| 0.043 | 0.029 | 0.043 | GABA B receptor antagonist | |||
| 0.019 | 0.006 | 0.019 | CDK2/cyclin A3 inhibitor | |||
| 0.057 | 0.044 | 0.057 | Sphingosine kinase inhibitor | |||
| 0.056 | 0.043 | 0.056 | Adenosine A1 receptor antagonist | |||
| 0.027 | 0.014 | 0.027 | Acid ceramidase inhibitor | |||
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.021 | 0.008 | 0.021 | CXC chemokine 5 receptor antagonist | |||
| 0.205 | 0.192 | 0.205 | Immunosuppressant | |||
| 0.015 | 0.003 | 0.015 | DNA topoisomerase III inhibitor | 0.011 0.003 CID_8656 | ||
| 0.037 | 0.025 | 0.037 | Integrin alpha2 antagonist | |||
| 0.023 | 0.01 | 0.025 | Factor XIII inhibitor | 0.025 0.008 CID_8656 | CID_8656 | |
| 0.028 | 0.015 | 0.037 | Thyroid hormone agonist | 0.037 0.007 CID_8656 | CID_8656 | |
| 0.053 | 0.041 | 0.053 | Glucosylceramidase inhibitor | 0.05 0.048 CID_8656 | ||
| 0.03 | 0.018 | 0.03 | Uridine phosphorylase inhibitor | |||
| 0.027 | 0.015 | 0.027 | Vanilloid 2 agonist | |||
| 0.1 | 0.089 | 0.1 | TRKA antagonist | |||
| 0.06 | 0.049 | 0.06 | Beta 2 adrenoreceptor agonist | |||
| 0.056 | 0.045 | 0.09 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.09 0.02 CID_8656 | CID_8656 | |
| 0.029 | 0.018 | 0.029 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.026 | 0.015 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.087 | 0.076 | 0.087 | Vascular endothelial growth factor 1 antagonist | |||
| 0.058 | 0.048 | 0.058 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.02 | 0.01 | 0.02 | Antibiotic Anthracycline-like | |||
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.038 | 0.028 | 0.038 | Urate transporter 1 inhibitor | |||
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.029 | 0.018 | 0.029 | DNA polymerase III inhibitor | |||
| 0.038 | 0.028 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.056 | 0.046 | 0.056 | Heat shock protein 90 beta antagonist | |||
| 0.028 | 0.018 | 0.028 | Glucosylceramidase stimulant | 0.027 0.019 CID_8656 | ||
| 0.041 | 0.031 | 0.041 | Oxytocin agonist | |||
| 0.048 | 0.038 | 0.048 | Squalene epoxidase inhibitor | |||
| 0.059 | 0.049 | 0.059 | I kappa B kinase 2 inhibitor | |||
| 0.027 | 0.017 | 0.027 | Integrin alpha2beta1 antagonist | |||
| 0.034 | 0.024 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.048 | 0.039 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 CID_8656 | CID_8656 | |
| 0.059 | 0.051 | 0.059 | Phosphodiesterase 1C inhibitor | |||
| 0.147 | 0.139 | 0.147 | Dyrk kinase inhibitor | |||
| 0.028 | 0.02 | 0.028 | Thrombin receptor antagonist | |||
| 0.103 | 0.094 | 0.155 | Nav1.3 sodium channel blocker | 0.155 0.044 CID_8656 | CID_8656 | |
| 0.064 | 0.056 | 0.118 | Prostaglandin-E synthase inhibitor | 0.118 0.02 CID_8656 | CID_8656 | |
| 0.026 | 0.018 | 0.026 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.105 | 0.097 | 0.163 | Toll-Like receptor 2 antagonist | 0.163 0.044 CID_8656 | CID_8656 | |
| 0.043 | 0.035 | 0.043 | Phosphorylase inhibitor | |||
| 0.025 | 0.018 | 0.025 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.045 | 0.038 | 0.049 | Benzodiazepine antagonist | 0.049 0.028 CID_8656 | CID_8656 | |
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.032 | 0.025 | 0.035 | Calcium release-activated channel blocker | 0.035 0.02 CID_8656 | CID_8656 | |
| 0.099 | 0.092 | 0.099 | MAO inhibitor | |||
| 0.056 | 0.049 | 0.056 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.041 | 0.035 | 0.041 | Glutamate (mGluR4) antagonist | |||
| 0.037 | 0.03 | 0.037 | Histone deacetylase class I inhibitor | |||
| 0.032 | 0.026 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.029 | 0.023 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.018 | 0.012 | 0.018 | Sodium/hydrogen exchanger inhibitor | |||
| 0.042 | 0.036 | 0.042 | Mannosidase inhibitor | |||
| 0.083 | 0.078 | 0.083 | Protein kinase C zeta inhibitor | |||
| 0.027 | 0.022 | 0.041 | Cyclin E2 inhibitor | 0.041 0.012 CID_8656 | CID_8656 | |
| 0.038 | 0.033 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.058 | 0.053 | 0.058 | Purinergic P2X2 antagonist | |||
| 0.076 | 0.072 | 0.076 | Caspase 7 inhibitor | |||
| 0.013 | 0.009 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.047 | 0.043 | 0.055 | Potassium channel (Inward rectifier) activator | 0.055 0.027 CID_8656 | CID_8656 | |
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.121 | 0.117 | 0.121 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.116 CID_8656 | ||
| 0.02 | 0.016 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.055 | 0.052 | 0.055 | 5 Hydroxytryptamine 2A agonist | |||
| 0.02 | 0.017 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.045 | 0.042 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 CID_8656 | CID_8656 | |
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.017 | 0.015 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.036 | 0.034 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.027 | 0.026 | 0.034 | Lysophosphatidic acid 2 receptor antagonist | 0.034 0.017 CID_8656 | CID_8656 | |
| 0.009 | 0.008 | 0.009 | Progesterone receptor A antagonist | |||
| 0.058 | 0.057 | 0.071 | Histone deacetylase SIRT3 inhibitor | 0.071 0.027 CID_8656 | CID_8656 | |
| 0.034 | 0.033 | 0.034 | Glutamate (mGluR group II) antagonist | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.035 | 0.036 | 0.036 | Vanilloid 3 antagonist | 0.036 0.033 CID_8656 | CID_8656 | |
| 0.011 | 0.014 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_8656 | CID_8656 | |
| 0.083 | 0.086 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | 0.107 0.049 CID_8656 | CID_8656 | |
| 0.064 | 0.069 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | 0.066 0.065 CID_8656 | CID_8656 | |
| 0.018 | 0.023 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_8656 | CID_8656 | |
| 0.014 | 0.019 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.006 CID_8656 | CID_8656 | |
| 0.006 | 0.011 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 CID_8656 | CID_8656 | |
| 0.018 | 0.025 | 0.029 | Protease (Human cytomegalovirus) inhibitor | 0.029 0.008 CID_8656 | CID_8656 | |
| 0.026 | 0.035 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 CID_8656 | CID_8656 | |
| 0.037 | 0.045 | 0.05 | Carbonic anhydrase VII inhibitor | 0.05 0.027 CID_8656 | CID_8656 | |
| 0.101 | 0.11 | 0.121 | Cytokine production inhibitor | 0.121 0.089 CID_8656 | CID_8656 | |
| 0.021 | 0.032 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.017 CID_8656 | CID_8656 | |
| 0.009 | 0.019 | 0.015 | Carbonic anhydrase XI inhibitor | 0.015 0.006 CID_8656 | CID_8656 | |
| 0.011 | 0.023 | 0.021 | Carbonic anhydrase X inhibitor | 0.021 0.008 CID_8656 | CID_8656 | |
| 0.011 | 0.023 | 0.021 | Carbonic anhydrase VIII inhibitor | 0.021 0.008 CID_8656 | CID_8656 | |
| 0.009 | 0.021 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.007 CID_8656 | CID_8656 | |
| 0.046 | 0.058 | 0.066 | Heparanase inhibitor | 0.066 0.015 CID_8656 | CID_8656 | |
| 0.056 | 0.07 | 0.151 | Catalase inhibitor | 0.151 0.026 CID_8656 | CID_8656 | |
| 0.032 | 0.045 | 0.044 | Carbonic anhydrase IV inhibitor | 0.044 0.029 CID_8656 | CID_8656 | |
| 0.024 | 0.039 | 0.045 | Epoxide hydrolase 1 inhibitor | 0.045 0.008 CID_8656 | CID_8656 | |
| 0.044 | 0.06 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 CID_8656 | CID_8656 | |
| 0.05 | 0.066 | 0.056 | Leukotriene C antagonist | 0.056 0.041 CID_8656 | CID_8656 | |
| 0.073 | 0.092 | 0.087 | Protein kinase (CK2) inhibitor | 0.087 0.075 CID_8656 | CID_8656 | |
| 0.046 | 0.066 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.047 CID_8656 | CID_8656 | |
| 0.03 | 0.054 | 0.046 | Acetyl-CoA transferase 1 inhibitor | 0.046 0.021 CID_8656 | CID_8656 | |
| 0.085 | 0.109 | 0.125 | Proteasome inhibitor | 0.125 0.061 CID_8656 | CID_8656 | |
| 0.029 | 0.054 | 0.037 | MAP3K5 inhibitor | 0.037 0.03 CID_8656 | CID_8656 | |
| 0.163 | 0.19 | 0.266 | Transcription factor STAT3 inhibitor | 0.266 0.072 CID_8656 | CID_8656 | |
| 0.036 | 0.062 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.04 CID_8656 | CID_8656 | |
| 0.027 | 0.057 | 0.055 | CDK5/p25 inhibitor | 0.055 0.018 CID_8656 | CID_8656 | |
| 0.052 | 0.084 | 0.063 | Beta 3 adrenoreceptor antagonist | 0.063 0.048 CID_8656 | CID_8656 | |
| 0.109 | 0.144 | 0.133 | Thiol protease inhibitor | 0.133 0.091 CID_8656 | CID_8656 | |
| 0.02 | 0.055 | 0.051 | Nicotinic acid receptor agonist | 0.051 0.014 CID_8656 | CID_8656 | |
| 0.011 | 0.047 | 0.029 | Bradykinin B2 receptor antagonist | 0.029 0.023 CID_8656 | CID_8656 | |
| 0.114 | 0.154 | 0.132 | DNA methyltransferase I inhibitor | 0.132 0.127 CID_8656 | CID_8656 | |
| 0.082 | 0.125 | 0.132 | Caspase 3 inhibitor | 0.132 0.044 CID_8656 | CID_8656 | |
| 0.11 | 0.154 | 0.138 | Death-associated protein kinase 1 inhibitor | 0.138 0.061 CID_8656 | CID_8656 | |
| 0.042 | 0.087 | 0.059 | DNA helicase inhibitor | 0.059 0.029 CID_8656 | CID_8656 | |
| 0.012 | 0.065 | 0.019 | Caspase 8 inhibitor | 0.019 0.016 CID_8656 | CID_8656 | |
| 0.016 | 0.089 | 0.033 | Cyclophilin A inhibitor | 0.033 0.019 CID_8656 | CID_8656 | |
| 0.034 | 0.112 | 0.055 | Fatty acid synthase inhibitor | 0.055 0.042 CID_8656 | CID_8656 | |
| 0.084 | 0.169 | 0.101 | Interleukin 2 antagonist | 0.101 0.089 CID_8656 | CID_8656 | |
| 0.039 | 0.135 | 0.052 | Adenine nucleotide translocase inhibitor | 0.052 0.048 CID_8656 | CID_8656 | |
| 0.146 | 0.244 | 0.198 | Angiogenesis inhibitor | 0.198 0.172 CID_8656 | CID_8656 | |
| 0.032 | 0.13 | 0.077 | Vanilloid antagonist | 0.077 0.049 CID_8656 | CID_8656 | |
| 0.04 | 0.139 | 0.067 | Epoxide hydrolase inhibitor | 0.067 0.058 CID_8656 | CID_8656 | |
| 0.091 | 0.208 | 0.254 | Interleukin antagonist | 0.254 0.06 CID_8656 | CID_8656 | |
| 0.115 | 0.24 | 0.179 | Growth factor agonist | 0.179 0.088 CID_8656 | CID_8656 | |
| 0.019 | 0.149 | 0.046 | Nicotinic acid receptor 1 agonist | 0.046 0.023 CID_8656 | CID_8656 | |
| 0.126 | 0.279 | 0.232 | Peptidyltransferase inhibitor | 0.232 0.065 CID_8656 | CID_8656 | |
| 0.061 | 0.226 | 0.097 | CDC-like kinase 3 inhibitor | 0.097 0.086 CID_8656 | CID_8656 | |
| 0.074 | 0.259 | 0.122 | NOS3 expression enhancer | 0.122 0.111 CID_8656 | CID_8656 | |
| 0.009 | 0.195 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | 0.02 0.01 CID_8656 | CID_8656 | |
| 0.041 | 0.244 | 0.081 | Falcipain 2 inhibitor | 0.081 0.069 CID_8656 | CID_8656 | |
| 0.014 | 0.221 | 0.041 | Smo receptor antagonist | 0.041 0.029 CID_8656 | CID_8656 | |
| 0.042 | 0.25 | 0.085 | Falcipain inhibitor | 0.085 0.068 CID_8656 | CID_8656 | |
| 0.015 | 0.235 | 0.079 | Neuraminidase (Influenza A) inhibitor | 0.079 0.005 CID_8656 | CID_8656 | |
| 0.133 | 0.37 | 0.202 | Ca(v)3.3 blocker | 0.202 0.189 CID_8656 | CID_8656 | |
| 0.054 | 0.305 | 0.147 | CDK3/cyclin E inhibitor | 0.147 0.028 CID_8656 | CID_8656 | |
| 0.015 | 0.311 | 0.163 | Neuraminidase (influenza) inhibitor | 0.163 0.006 CID_8656 | CID_8656 | |
| 0.01 | 0.336 | 0.151 | Neuraminidase inhibitor | 0.151 0.005 CID_8656 | CID_8656 | |
| 0.085 | 0.417 | 0.164 | Cyclin-dependent kinase 3 inhibitor | 0.164 0.07 CID_8656 | CID_8656 | |
| 0.042 | 0.417 | 0.12 | Histone deacetylase SIRT1 inhibitor | 0.12 0.091 CID_8656 | CID_8656 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |